Comparing oxygen-sensitive MRI (BOLD R2*) with oxygen electrode measurements: A pilot study in men with prostate cancer

International Journal of Radiation Biology

Volumn 85, Issue 9, 2009, Pages 805-813

  Chopra, Supriya ^a,b   Foltz, Warren D ^b   Milosevic, Michael F ^a,b   Toi, Ants ^c   Bristow, Robert G ^a,b   Ménard, Cynthia ^a,b,e   Haider, Masoom A ^d  

^a Departments of Radiation Oncology   (Canada)

^b Radiation Medicine Programme   (Canada)

^c Departments of Medical Imaging   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

BOLD MRI; Hypoxia; Non invasive imaging; Prostate cancer

Indexed keywords

CARBONATE DEHYDRATASE IX; GLUCOSE TRANSPORTER 1; HYPOXIA INDUCIBLE FACTOR 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOCHEMISTRY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN ELECTRODE; OXYGEN TENSION; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; TISSUE OXYGENATION; TRANSRECTAL ULTRASONOGRAPHY;

AGED; BIOLOGICAL MARKERS; BIOPSY; CELL HYPOXIA; COHORT STUDIES; ELECTRODES; HUMANS; IMMUNOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYGEN; PILOT PROJECTS; PROSTATIC NEOPLASMS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; UP-REGULATION;

EID: 70249150678     PISSN: 09553002     EISSN: 13623095     Source Type: Journal    
DOI: 10.1080/09553000903043059     Document Type: Article

References (47)

1. Aihara M, Wheeler TM, Ohori M, Scardino PT. 1994. Hetero-geniety of prostate cancer in radical prostatectomy specimens. Urology 43:60-66. (Pubitemid 124019565)
2. An H, Lin W. 2002. Cerebral venous and arterial blood volumes can be estimated separately in humans using magnetic resonance imaging. Magnetic Resonance in Medicine 47:958-966.
3. Arumana JM, Li D, Dharmakumar R. 2008. Deriving blood-oxygen-level- dependent contrast in MRI with T2* weighted and T2 prepared and phase cycled SSFP methods: Theory and experiment. Magnetic Resonance in Medicine 59:561-570.
4. Baudelet C, Gallez B. 2002. How does Blood Oxygen Level Dependent (BOLD) contrast correlate with oxygen partial pressure inside tumors? Magnetic Resonance in Medicine 48:980-986.
5. Carnell DM, Smith RE, Daley FM, Saunders MI, Bentzen SM, Hoskin PJ. 2006. An immunohistochemical assessment of hypoxia in prostate carcinoma using pimonidazole: Implications of radioresistance. International Journal of Radiation Oncology, Biology, Physics 65:91-99.
6. Carreira GC, Gemeinhardt O, Beyersdorff D, Schnorr J, Taupitz M, Lüdemann L. 2009. Effects of water exchange on MRI-based determination of relative blood volume using an inversion-prepared gradient echo sequence and a blood pool contrast medium. Magnetic Resonance Imaging 27:360-369.
7. Cooper RA, Carrington BM, Loncaster JA, Todd SM, Davidson SE, Logue JP, Luthra AD, Jones AP, Stratford I, Hunter RD, West CM. 2000. Tumor oxygenation levels correlate with dynamic contrast enhanced imaging parameters in carcinoma of cervix. Radiotherapy and oncology: Journal of the European Society for Therapeutic Radiology and Oncology 57:53-59.
8. D'amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A. 1998. Biochemical outcome after radical prostatectomy, external beam radiotherapy, or interstitial radiation therapy for clinically localised prostate cancer. Journal of the American Medical Association 280:969-974. (Pubitemid 28445094)
9. Dehdashti F, Grigsby PW, Mintun MA, Lewis JS, Siegel BA, Welch MJ. 2003a. Assessing tumor hypoxia in cervical cancer by positron emission tomography with 60 Cu ATSM: Relationship to therapeutic response: A preliminary report. International Journal of Radiation Oncology, Biology, Physics 55:1233-1238.
10. Dehdashti F, Mintun MA, Lewis JS, Bradley J, Govindan R, Laforest R, Welch MJ, Siegel BA. 2003b. In vivo assessment of tumor hypoxia in lung cancer with 60 Cu-ATSM. European Journal of Nuclear Medicine and Molecular Imaging 30:844-850.
11. Evans SM, Hahn SM, Magarelli DP, Koch CJ. 2001. Hypoxic heterogeneity in human tumors: EF5 binding, vasculature, necrosis and proliferation. American Journal of Clinical Oncology 24:467-472.
12. Foltz WD, Huang H, Fort S, Wright GA. 2002. Vasodilator response assessment in porcine myocardium with magnetic resonance relaxometry. Circulation 106:2714-2719.
13. Foltz WD, Yang Y, Graham JJ, Detsky JS, Wright GA, Dick AJ. 2006. MRI relaxation fluctuations in acute reprefused hemorrhagic infarction. Magnetic Resonance in Medicine 56:1311-1319.
14. Fujita N, Matsumoto K, Tanaka H, Watanabe Y, Murase K. 2006. Quantitative study of changes in oxidative metabolism during visual stimulation using absolute relaxation rates. NMR Biomedicine 19:60-68.
15. Fujita N, Shinohara M, Tanaka H, Yutani K, Nakamura H, Murase K. 2003. Quantitative mapping of cerebral deoxyhemoglobin content using MR imaging. Neuroimage 20:2071-2083.
16. Fyles A, Milosevic M, Hedley D, Pintilie M, Levin W, Manchul L, Hill RP. 2002. Tumor hypoxia has independent predictor impact only in patients with node negative cervical cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20:680-687.
17. Gibbs P, Tozer DJ, Liney GP, Turnbull LW. 2001. Comparison of quantitative T2 mapping and diffusion weighted imaging in normal and pathologic prostate. Magnetic Resonance in Medicine 46:1054-1058.
18. He X, Yablonskiy DA. 2007. Quantitative BOLD: Mapping of human cerebral deoxygenated blood volume and oxygen extraction fraction: Default state. Magnetic Resonance in Medicine 57:115-126.
19. Henkelman RM, Hardy PA, Bishop JE, Poon CS, Plewes DB. 1992. Why fat is bright in RARE and fast spin echo imaging. Journal of Magnetic Resonance Imaging 2:533-540.
20. Hoge RD, Atkinson J, Gill B, Crelier GR, Marrett S, Pike GB. 1999. Investigation of BOLD signal dependence on cerebral blood flow and oxygen consumption in activated human cortex. Magnetic Resonance in Medicine 42:849-863. (Pubitemid 29521474)
21. Hoskin PJ, Carnell DM, Taylor NJ, Smith RE, Stirling JJ, Daley FM, Saunders MI, Bentzen SM, Collins DJ, d'Arcy JA, Padhani AP. 2007. Hypoxia in prostate cancer: Correlation of BOLD MRI with pimonidazole immunohistochemistry- initial observations. International Journal of Radiation Oncology, Biology, Physics 68:1065-1071.
22. Kavanagh MC, Sun A, Hu Q, Hill RP. 1996. Comparing techniques of measuring tumor hypoxia in different murine tumors: Eppendorf pO2 histograph,[3H]misonidazole binding and paired survival assay. Radiation Research 145:491-500.
23. Kjaer L, Thomsen C, Iversen P, Henriksen O. 1987. In vivo estimation of relaxation process in benign hyperplasia and carcinoma of prostate gland by magnetic resonance imaging. Magnetic Resonance Imaging 5:23-30.
24. Langer D, vander Kwast TH, Evans AJ, Sun l, Yaffe MJ, Trachtenberg J, Haider MA. 2008. Intermixed normal tissue within prostate cancer: Effect on MR imaging measurements of apparent diffusion coefficient and T2-sparse vs. dense cancers. Radiology 249:900-908.
25. Lee NY, Mechalakos JG, Nehmeh S, Lin Z, Squire OD, Cai S, Chan K, Zanzonico PB, Greco C, Ling CC, Humm JL, Schoder H. 2008. Florine-18 labelled misonidazole positron emission and computer tomography guided intensity modulated radiotherapy for head and neck cancer: A feasibility study. International Journal of Radiation Oncology, Biology, Physics 70:2-13.
26. Losert C, Peller M, Schneider P, Reiser M. 2002. Oxygen enhanced MRI of brain. Magnetic Resonance in Medicine 48:271-277.
27. Mason RP, Hunjan S, Constantinescu A, Song Y, Zhao D, Hahn EW, Antich PP, Peschke P. 2003. Tumor oximetry: Comparison of 19F MR EPI and electrodes. Advances in Experimental Medicine and Biology 530:19-27.
28. Mason RP, Rodbumrung W, Antich PP. 1996. Hexafluoroben-zene: A sensitive 19F NMR indicator of tumor oxygenation. NMR in Biomedicine 9:125-134.
29. Matsumoto K, Subramanian S, Devasahayam N, Aravalluvan T, Murugesan R, Cook JA, Mitchell JB, Krishna MC. 2006. Electron paramamgnetic resonance imaging of tumor hypoxia: Enhanced spatial and temporal resolution for in vivo pO2 determination. Magnetic Resonance in Medicine: Official Journal of the Society of Magnetic Resonance in Medicine 55:1157-1163.
30. Menard C, Susil RC, Choyke P, Coleman J, Grubb R, Gharib A, Krieger A, Guion P, Thomasson D, Ullman K, Gupta S, Espina V, Liotta L, Petricoin E, Fitchtinger G, Whitcomb LL, Atalar E, Coleman CN, Camphausen K. 2005. An interven-tional magnetic resonance imaging technique for the molecular characterization of intraprostatic dynamic contrast enhancement. Molecular imaging: Official Journal of the Society for Molecular Imaging 4:63-66.
31. Milosevic M, Bristow R, Chung P, Panzarella T, Toi A, Hill R. 2004a. Prostate cancer hypoxia correlates with poor patient outcome following treatment with radiotherapy. International Journal of Radiation Oncology, Biology, Physics 60:S236-237.
32. Milosevic M, Chung P, Parker C, Bristow R, Toi A, Panzarella T, Warde P, Catton C, Menard C, Bayley A, Gospodarowicz M, Hill R. 2007. Androgen withdrawal in patients reduces prostate cancer hypoxia: Implications for disease progression and radiation response. Cancer Research 67:6022-6025.
33. Milosevic M, Fyles A, Hedley D, Hill R. 2004b. The human tumor microenvironment: Invasive (needle) measurement of oxygen and interstitial fluid pressure. Seminars in Radiation Oncology 14:249-258.
34. Movsas B, Chapman JD, Greenberg RE, Hanlon AL, Horwitz EM, Pinover WH, Stobbe C, Hanks GE. 2000. Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: An Eppendorf pO(2) study. Cancer 89:2018-2024.
35. Movsas B, Chapman JD, Hanlon AL, Horwitz EM, Greenberg RE, Stobbe C, Hanks GE, Pollack A. 2002. Hypoxic prostate/ muscle pO2 ratio predicts for biochemical failure in patients with prostate cancer: Preliminary findings. Urology 60:634-639.
36. Movsas B, Chapman JD, Hanlon AL, Horwitz EM, Pinover WH, Greenberg RE, Stobbe C, Hanks GE. 2001. Hypoxia in human prostate carcinoma: An Eppendorf PO2 study. American Journal of Clinical Oncology 24:458-461.
37. Movsas B, Chapman JD, Horwitz EM, Pinover WH, Greenberg RE, Hanlon AL, Iyer R, Hanks GE. 1999. Hypoxic regions exist in human prostate carcinoma. Urology 53:11-18.
38. Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, Becker A, Adam M, Molls M, Dunst J, Terris DJ, Overgaard J. 2005. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiotherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 77:18-24.
39. Ogawa S, Lee TM, Kay AR, Tank DW. 1990. Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proceedings of the National Academy of Sciences of the USA 87:9868-9872.
40. Oh J, Cha S, Aiken AH, Han ET, Crane JC, Stainsby JA, Wright GA, Dillon WP, Nelson SJ. 2005. Quantitative apparent diffusion coefficients and T2 relaxation time in characterizing contrast enhancing brain tumors and regions of peritumoral edema. Journal of Magnetic Resonance Imaging 21:701-708.
41. Padhani AR, Krohn KA, Lewis JS, Alber M. 2007. Imaging oxygenation of human tumours. European Radiology 17:861-872.
42. Parker C, Milosevic M, Toi A, Sweet J, Panzarella T, Bristow R, Catton C, Catton P, Crook J, Gospodarowicz M, McLean M, Warde P, Hill RP. 2004. Polarographic electrode study of tumor oxygenation in clinically localized prostate cancer. International Journal of Radiation Oncology, Biology, Physics 58:750-757.
43. Rajendran JG, Wilson DC, Conrad EU, Peterson LM, Bruckner JD, Rasey JS, Chin LK, Hofstrand PD, Grierson JR, Eary JF, Krohn KA. 2003. (18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: Correlation of hypoxia, metabolism and VEGF expression. European Journal of Nuclear Medicine and Molecular Imaging 30:695-704.
44. Reeder SB, Faranesh AZ, Boxerman JL, McVeigh ER. 1998. In vivo measurement of T*2 and field inhomogeneity maps in the human heart at 1.5 T. Magnetic Resonance in Medicine 39:988-998.
45. Souvatzoglou M, Grosu AL, Roper B, Krause BJ, Beck R, Reischl G, Picchio M, Machulla HJ, Wester HJ, Piert M. 2007. Tumour hypoxia imaging with [(18)F]FAZA PET in head and neck cancer patients: A pilot study. European Journal of Nuclear Medicine and Molecular Imaging 34:1566-1575.
46. Vergis R, Corbishley CM, Norman AR, Bartlett J, Jhavar S, Borre M, Heeboll S, Horwich A, Huddart R, Khoo V, Eeles R, Cooper C, Sydes M, Dearnaley D, Parker C. 2008. Intrinsic markers of tumour hypoxia and angiogenesis in localised prostate cancer and outcome of radical treatment: A retrospective analysis of two randomised radiotherapy trials and one surgical cohort study. The Lancet Oncology 9:342-351.
47. Wong RK, Fyles A, Milosevic M, Pintilie M, Hill RP. 1997. Heterogeneity of polarographic oxygen tension measurements in cervix cancer: An evaluation of within and between tumor variability, probe position, and track depth. International Journal of Radiation Oncology, Biology, Physics 39:405-412.